ANDREA STAHL: Open Payments
NPI 1467701847 · MESA, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$977 in 38 payments from 23 companies in 2025. Trend: 2023 $49 · 2024 $225 · 2025 $977
Food & beverage: $977
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 3 | $151 |
| E.R. Squibb & Sons, L.L.C. | 1 | $127 |
| Novo Nordisk Inc | 5 | $101 |
| Lilly USA, LLC | 4 | $81 |
| Novartis Pharmaceuticals Corporation | 3 | $68 |
| Astellas Pharma US Inc | 2 | $49 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 2 | $46 |
| Impulse Dynamics (USA) Inc. | 2 | $42 |
| ABBVIE INC. | 1 | $33 |
| Amgen Inc. | 2 | $29 |
Products named: BREZTRI, CAMZYOS, LEQVIO, Wegovy, Veozah, LifeVest, Optimizer, JARDIANCE.
Industry payments across AZ — which companies pay providers there.
